Form 8-K - Current report:
SEC Accession No. 0000950170-23-027254
Filing Date
2023-06-09
Accepted
2023-06-09 16:05:38
Documents
12
Period of Report
2023-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sana-20230608.htm   iXBRL 8-K 80379
  Complete submission text file 0000950170-23-027254.txt   208647

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sana-20230608_lab.xml EX-101.LAB 18527
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sana-20230608.xsd EX-101.SCH 2450
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sana-20230608_pre.xml EX-101.PRE 11544
6 EXTRACTED XBRL INSTANCE DOCUMENT sana-20230608_htm.xml XML 4890
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 231005244
SIC: 2836 Biological Products, (No Diagnostic Substances)